Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pritash Patel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|May 17, 2006
Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowelJames E Huddy, Pritash Patel, Matthew W Johnson, et al.
Inflammatory Bowel Diseases|November 20, 2009
Subepithelial dendritic B cells in orofacial granulomatosisPritash Patel, Francesca Barone, Carlo Nunes, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|January 21, 2011
Experience with anti-TNF-α therapy for orofacial granulomatosisTim Elliott, Helen Campbell, Michael Escudier, et al.
Clinical and Translational Allergy|August 17, 2013
Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel diseasePritash Patel, Jonathan Brostoff, Helen Campbell, et al.
Rheumatology (Oxford, England)|May 26, 2012
Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigenYuan Zhao, Edward Odell, Lee Meng Choong, et al.
Inflammatory Bowel Diseases|September 13, 2011
Distinguishing orofacial granulomatosis from crohn's disease: two separate disease entities?Helen Campbell, Michael Escudier, Pritash Patel, et al.
Inflammatory Bowel Diseases|June 17, 2016
Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial GranulomatosisAlexander Mentzer, Shalini Nayee, Yasmin Omar, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2019
Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patientsChristian P Selinger, Gareth C Parkes, Ash Bassi, et al.
The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|May 17, 2006
Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowelJames E Huddy, Pritash Patel, Matthew W Johnson, et al.
Inflammatory Bowel Diseases|November 20, 2009
Subepithelial dendritic B cells in orofacial granulomatosisPritash Patel, Francesca Barone, Carlo Nunes, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|January 21, 2011
Experience with anti-TNF-α therapy for orofacial granulomatosisTim Elliott, Helen Campbell, Michael Escudier, et al.
Clinical and Translational Allergy|August 17, 2013
Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel diseasePritash Patel, Jonathan Brostoff, Helen Campbell, et al.
Rheumatology (Oxford, England)|May 26, 2012
Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigenYuan Zhao, Edward Odell, Lee Meng Choong, et al.
Inflammatory Bowel Diseases|September 13, 2011
Distinguishing orofacial granulomatosis from crohn's disease: two separate disease entities?Helen Campbell, Michael Escudier, Pritash Patel, et al.
Inflammatory Bowel Diseases|June 17, 2016
Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial GranulomatosisAlexander Mentzer, Shalini Nayee, Yasmin Omar, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2019
Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patientsChristian P Selinger, Gareth C Parkes, Ash Bassi, et al.
The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.
Pageof 1